Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 14, 2023
Date Accepted: Aug 21, 2023

The final, peer-reviewed published version of this preprint can be found here:

Determining the Impact of Opioid Policy on Substance Use and Mental Health–Related Harms: Protocol for a Data Linkage Study

Xia T, Picco L, Lalic S, Buchbinder R, Bell J, Andrew NE, Lubman DI, Pearce C, Nielsen S

Determining the Impact of Opioid Policy on Substance Use and Mental Health–Related Harms: Protocol for a Data Linkage Study

JMIR Res Protoc 2023;12:e51825

DOI: 10.2196/51825

PMID: 37847553

PMCID: 10618880

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Title: Determining the impact of opioid policy on substance use and mental health related harms: protocol for a data linkage study

  • Ting Xia; 
  • Louisa Picco; 
  • Samanta Lalic; 
  • Rachelle Buchbinder; 
  • J.Simon Bell; 
  • Nadine E Andrew; 
  • Dan I Lubman; 
  • Christopher Pearce; 
  • Suzanne Nielsen

ABSTRACT

Introduction Increasing harms related to prescription opioids over the past decade has led to the introduction of a range of key national and state policy initiatives across Australia. However, similar opioid policies internationally have had mixed outcomes, including unintended adverse consequences. There is little real-world evidence on how these policy levers work in Australia. Using a linked dataset, this project aims to examine if changes to opioid prescribing policies have impacted prescription opioid-related harms. Method and analyses This is a population linked data study using data from general practice health records obtained from the Population Level Analysis and Reporting (POLAR) platform and linked with person-level data from three large hospital networks in Victoria, Australia. Interrupted time series (ITS) will be used to examine the impact of opioid policies on a range of harms including the incidence of presentations related to substance use (opioid and non-opioid), and mental ill-health among the primary care cohort. Group-based trajectory modelling and a case-crossover design will be used to further explore the impact of changes in opioid dosage and other covariates on opioid and non-opioid poisonings, and mental ill-health related presentations at the patient-level. Ethics and dissemination Ethics approval was obtained from the Monash University Human Research Ethics Committee (ID 76744), Monash Health (RES-22-0000-026A), Peninsula Health (SSA/76744/PH-2022), and Eastern Health (S22-032-76744). Dissemination will occur by engaging stakeholders through reference groups and steering committees, as well as the production of research translation resources in parallel with peer-reviewed publications and conference presentations. Protocol registration details EU PAS Register (EUPAS104005)


 Citation

Please cite as:

Xia T, Picco L, Lalic S, Buchbinder R, Bell J, Andrew NE, Lubman DI, Pearce C, Nielsen S

Determining the Impact of Opioid Policy on Substance Use and Mental Health–Related Harms: Protocol for a Data Linkage Study

JMIR Res Protoc 2023;12:e51825

DOI: 10.2196/51825

PMID: 37847553

PMCID: 10618880

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.